Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-31), Azelis Group NV's 14-Day RSI is 72.97.
The industry rank for Azelis Group NV's 14-Day RSI or its related term are showing as below:
FRA:2R7's 14-Day RSI is ranked worse than 96% of 1652
companies
in the Chemicals industry
Industry Median: 44.73
vs FRA:2R7: 72.97
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Azelis Group NV 14-Day RSI Related Terms
FRA:2R7 vs LIN, SHW, ECL: 14-Day RSI Comparison
For the Specialty Chemicals subindustry, Azelis Group NV's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Azelis Group NV 14-Day RSI vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Azelis Group NV's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Azelis Group NV's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Azelis Group NV (FRA:2R7) has a 14-Day RSI of 72.97 as of Jul. 31, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Azelis Group NV and its competitors. According to the industry distribution chart, Azelis Group NV ranks #1586 out of 1652 companies in the Chemicals industry, placing it in the top 96%.
Is Azelis Group NV's 14-Day RSI too high?
Azelis Group NV's current 14-Day RSI is 72.97. The Chemicals industry median 14-Day RSI is 44.73. Azelis Group NV's value of 72.97 is 63.1% above this industry median. Based on the distribution chart, Azelis Group NV ranks #1586 out of 1652 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Azelis Group NV has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Azelis Group NV's 14-Day RSI compare to LIN and SHW?
According to the Chemicals industry distribution chart, Azelis Group NV ranks #1586 out of 1652 companies for 14-Day RSI. This places Azelis Group NV in the lower half of its industry. The industry median 14-Day RSI is 44.73. Azelis Group NV's value of 72.97 is 63.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Chemicals company?
The median 14-Day RSI among Chemicals companies is 44.73, based on 1,652 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Azelis Group NV's current 14-Day RSI of 72.97 is 63.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Azelis Group NV and its competitors. For the Chemicals industry, the median 14-Day RSI is 44.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Azelis Group NV's current 14-Day RSI is 72.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Azelis Group NV stock overvalued right now?
Based on GuruFocus' analysis, Azelis Group NV (FRA:2R7) is currently considered Significantly Undervalued. The stock's GF Value™ is €19.05, compared to a current price of €11.70 — trading 38.6% below its estimated fair value. The current 14-Day RSI is 72.97 and 63.1% above the Chemicals industry median of 44.73. Azelis Group NV's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Azelis Group NV (FRA:2R7), the current 14-Day RSI is 72.97 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Azelis Group NV (FRA:2R7) Overvalued in 2026?
Based on GuruFocus' analysis, Azelis Group NV stock appears to be undervalued.
The current stock price of €11.70 is trading 38.6% below its estimated GF Value™ of €19.05.
GuruFocus considers Azelis Group NV to be Significantly Undervalued.
Key valuation signals for FRA:2R7:
14-Day RSI: 72.97
GF Value™: €19.05 vs. price of €11.70 (38.6% below fair value)
Industry Position: 63.1% above the Chemicals median (#1586 of 1652)
No single metric tells the full story. See the FRA:2R7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Azelis Group NV is an innovation service provider and distributor of speciality chemicals and food ingredients. The Group provides innovation services, multi-product formulations, technical and regulatory expertise, co-creation support, digital solutions, and supply chain services. It serves Food & Nutrition, Animal Nutrition, Personal Care, Home Care & Industrial Cleaning, Pharmaceuticals & Healthcare, Agriculture & Environmental Solutions, Flavours & Fragrances, and Nutraceuticals. The Group operates through four segments: EMEA, Americas, Asia Pacific, and Group holding & other, covering operating companies across Europe, the Middle East and Africa, the United States, Canada, Mexico and South America, Asia, and the Pacific region.
74GF Score
Get the complete analysis for FRA:2R7
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2R7 has been successfully added to your 
